ERISA Ledger · U.S. DOL EBSA Form 5500 (2023)

Astrazeneca Pharmaceuticals LP

Official 2023 U.S. DOL Form 5500 summary for Astrazeneca Pharmaceuticals LP (Astrazeneca Defined Benefit Pension Plan · EIN 23-2967016 · PN 001): $0.00 net assets, 0 active participants, and Sponsor-paid or unbenchmarked.

Reported Form 5500 Fee & Service Summary

Plan SponsorAstrazeneca Pharmaceuticals LP
Filing IdentifierAstrazeneca Defined Benefit Pension Plan · EIN 23-2967016 · PN 001
Plan Category & StateDefined Benefit & Cash Balance (DE)
Asset-Size Peer Cohort<$1M
Plan Net Assets (2023)$0.00
Active Participants0
Direct Admin Fee RateSponsor-paid or unbenchmarked
Cohort Peer MedianN/A
Primary Recordkeeper / ProviderUnbundled / Direct Trust
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI

Cross-Agency Entity Graph

Related Filings Across Meru Platforms

Verified federal filings reconciled for AstraZeneca across sibling Meru AI platforms.